These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10269044)

  • 1. Audit of digoxin prescribing in ambulatory patients.
    Wiser TH; Michocki RJ; Knapp DA; Knapp DA; Ilioff SM
    Hosp Pharm; 1984 Dec; 19(12):811-6. PubMed ID: 10269044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Audit of phenytoin prescribing for outpatients.
    Curry CE; Antal EG; Keys PW; Duffy MG
    Am J Hosp Pharm; 1981 Aug; 38(8):1158-60. PubMed ID: 7270560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncompliance with congestive heart failure therapy in the elderly.
    Monane M; Bohn RL; Gurwitz JH; Glynn RJ; Avorn J
    Arch Intern Med; 1994 Feb; 154(4):433-7. PubMed ID: 8117176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congestive heart failure with sinus rhythm. Audit of digoxin therapy in a family medicine teaching unit.
    Hendry J
    Can Fam Physician; 1993 Dec; 39():2541-5. PubMed ID: 8292929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a therapeutic drug monitoring program for digoxin.
    Wing D; Duff HJ
    Arch Intern Med; 1987 Aug; 147(8):1405-8. PubMed ID: 3632149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin prescribing for heart failure in elderly residents of long-term care facilities.
    Misiaszek B; Heckman GA; Merali F; Turpie ID; Patterson CJ; Flett N; McKelvie RS
    Can J Cardiol; 2005 Mar; 21(3):281-6. PubMed ID: 15776118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin use and digoxin toxicity in the post-DIG trial era.
    Hussain Z; Swindle J; Hauptman PJ
    J Card Fail; 2006 Jun; 12(5):343-6. PubMed ID: 16762795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessment of indications for digoxin. Are patients being withdrawn?
    Sueta CA; Carey TS; Burnett CK
    Arch Intern Med; 1989 Mar; 149(3):609-12. PubMed ID: 2919937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of digoxin on the quality of life in patients with heart failure.
    Lader E; Egan D; Hunsberger S; Garg R; Czajkowski S; McSherry F
    J Card Fail; 2003 Feb; 9(1):4-12. PubMed ID: 12612867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin therapeutic drug monitoring: an audit and review.
    Sidwell A; Barclay M; Begg E; Moore G
    N Z Med J; 2003 Dec; 116(1187):U708. PubMed ID: 14752536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of an individualized patient education program about digoxin.
    Soflin D; Young WW; Clayton BD
    Am J Hosp Pharm; 1977 Apr; 34(4):367-71. PubMed ID: 67805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.
    Cox JL; Ramer SA; Lee DS; Humphries K; Pilote L; Svenson L; Tu JV;
    Can J Cardiol; 2005 Mar; 21(4):337-43. PubMed ID: 15838560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary audit of digoxin.
    Keys PW; DeSantis D; Duffy MG
    Am J Hosp Pharm; 1978 Aug; 35(8):935-8. PubMed ID: 677140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey.
    Sturm HB; van Gilst WH; Veeger N; Haaijer-Ruskamp FM
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):96-103. PubMed ID: 16528759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the economic value of digoxin therapy in congestive heart failure patients? Results from the DIG trial.
    Eisenstein EL; Yusuf S; Bindal V; Bourassa MG; Horney A; Collins JF; Mark DB;
    J Card Fail; 2006 Jun; 12(5):336-42. PubMed ID: 16762794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on digoxin therapy in congestive heart failure.
    Haji SA; Movahed A
    Am Fam Physician; 2000 Jul; 62(2):409-16. PubMed ID: 10929703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin for the treatment of fetal congestive heart failure with sinus rhythm assessed by cardiovascular profile score.
    Patel D; Cuneo B; Viesca R; Rassanan J; Leshko J; Huhta J
    J Matern Fetal Neonatal Med; 2008 Jul; 21(7):477-82. PubMed ID: 18570128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic burden of congestive heart failure in a managed care population.
    Xuan J; Duong PT; Russo PA; Lacey MJ; Wong B
    Am J Manag Care; 2000 Jun; 6(6):693-700. PubMed ID: 10977478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.